Public health surveillance is a vital tool for understanding the health of a population and informing public health decision-making. It involves the systematic collection and analysis of health-related data, which can be used to identify trends and patterns, assess the effectiveness of interventions, and plan and evaluate public health programs.
A central goal of public health is to achieve equity within our communities. By concentrating on community-wide prevention and overall health, public health improves our quality of life, saves money for our communities, helps children thrive, and reduces human suffering.
Genomics can maintain public health and wellness by detecting and characterizing new, emerging, and circulating pathogens. By tracking and monitoring infectious agent transmission and disease spread within a community, we can better understand pathogen behavior (infectivity and pathogenicity) and map the evolution of variants. This will ultimately aid the development of diagnostics and design of therapeutic vaccines and treatments.
Provide data to track pathogens over time across geographical regions.
Identify extremely rare or newly emergent pathogens causing disease.
Determine and classify pathogen strains.
Identify the existence of known or discover new antimicrobial resistance markers to inform future treatment strategies.
Advance early pathogen detection, improve outbreak responses, and support research for emerging pathogens.
Learn about highly sensitive NGS approaches to identify novel coronavirus mutations, track transmission, study viral genetics, and more.
NGS supports effective genomic surveillance strategies to help reduce transmission and infection.
Wastewater surveillance is useful for community-level monitoring of emerging infectious diseases, mutation tracking, and variant trend tracking.
Obtain whole-genome sequencing (WGS) data that can characterize 66 viruses that are of high risk to public health, including SARS-CoV-2, Influenza, Monkeypox Virus, and Poliovirus.
A high-throughput, next-generation sequencing test for SARS-CoV-2 surveillance and enables virus genome analysis in research use.
A next-generation sequencing (NGS)-based respiratory pathogen panel that delivers highly sensitive, comprehensive pathogen detection and antimicrobial resistance (AMR) insights.
A next-generation sequencing (NGS) panel that detects and quantifies over 170 common, less common, challenging-to-grow, and frequently missed uropathogens.
A highly sensitive NGS panel to detect and characterize common respiratory viruses, including COVID-19 strains, with comprehensive, rapid target enrichment sequencing.
Watch Dr. James Wood and Dr. William Haseltine discuss the current state of infectious disease surveillance, its strengths, and shortcomings.
Read how NGS-based methods are revolutionizing high-throughput sequencing for surveillance.
This downloadable brochure outlines how genomics plays a role in public health surveillance and the tools used for various surveillance methods.